Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytosorbents Cor (NQ: CTSO ) 1.050 +0.010 (+0.96%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cytosorbents Cor < Previous 1 2 3 4 Next > CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress July 17, 2024 From CytoSorbents Via GlobeNewswire Why CytoSorbents (CTSO) Stock Is Trading Higher July 02, 2024 CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group. Via Benzinga CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union June 13, 2024 By enabling more rapid and easy treatment, PuriFi is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification cartridge for critically ill patients in the... From CytoSorbents Via GlobeNewswire Recap: CytoSorbents Q4 Earnings March 14, 2024 Via Benzinga A Preview Of CytoSorbents's Earnings March 13, 2024 Via Benzinga CytoSorbents Secures $20 Million Credit Facility July 02, 2024 Credit facility provides timely non-dilutive capital to support ongoing global commercialization of CytoSorb® as well as regulatory submissions and potential commercialization plans for DrugSorb™-ATR... From CytoSorbents Via GlobeNewswire CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting June 05, 2024 From CytoSorbents Via GlobeNewswire What To Know About HC Wainwright & Co.'s Downgrade of CytoSorbents December 29, 2023 Via Benzinga CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan June 24, 2024 Brings a powerful blood purification technology used to treat critically ill and cardiac surgery patients in nearly a quarter million treatments across 75 countries to date to one of the most... From CytoSorbents Via GlobeNewswire CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract June 04, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024 May 09, 2024 CTSO stock results show that CytoSorbents met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace CytoSorbents Reports First Quarter 2024 Results May 09, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe May 02, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Report First Quarter 2024 Operating and Financial Results April 26, 2024 From CytoSorbents Via GlobeNewswire STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting April 17, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023 March 14, 2024 CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace CytoSorbents Reports Fourth Quarter and Full Year 2023 Results March 14, 2024 From CytoSorbents Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga CytoSorbents to Report Fiscal 2023 Operating and Financial Results March 06, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference February 08, 2024 From CytoSorbents Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 17, 2024 Via Benzinga Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients January 17, 2024 CytoSorb Blood Purification Results in Statistically Significant Reductions in Multiple Organ Failure and Dysfunction From CytoSorbents Via GlobeNewswire CYTOSORBENTS ALERT: Bragar Eagel & Squire, P.C. is Investigating Cytosorbents Corporation on Behalf of Cytosorbents Stockholders and Encourages Investors to Contact the Firm January 08, 2024 From Bragar Eagel & Squire Via GlobeNewswire Gold Moves Lower; US Crude Stocks Decline Last Week December 28, 2023 U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.... Via Benzinga Topics Stocks Exposures US Equities Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session December 28, 2023 Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program. Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session December 28, 2023 Via Benzinga Crude Oil Down 1%; US Wholesale Inventories Fall In November December 28, 2023 U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Thursday. The Dow traded up 0.14% to 37,708.15 while the NASDAQ rose 0.19% to 15,127.17. The... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Dow Gains 50 Points; US Jobless Claims Rise To 218,000 December 28, 2023 U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Thursday. Following the market opening Thursday, the Dow traded up 0.14% to 37,708.72 while the NASDAQ rose... Via Benzinga Topics Stocks Exposures US Equities Why Is Blood Purification Focused CytoSorbents Trading Lower Today? December 28, 2023 CytoSorbents Corporation (NASDAQ: CTSO) released an update on the initial data analysis of primary safety and effectiveness endpoints and the final independent Data and Safety Monitoring Board for the... Via Benzinga 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 28, 2023 Via Benzinga < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.